Cogprints

Syphilis serology in HIV-positive and HIV-negative Nigerians: The public health significance

Uneke Jesse, Chigozie and Ogbu, Ogbonnaya and Alo, Moses and Ariom, Thaddeus (2006) Syphilis serology in HIV-positive and HIV-negative Nigerians: The public health significance. [Journal (On-line/Unpaginated)]

Full text available as:

[img]
Preview
PDF
199Kb

Abstract

Syphilis has acquired new potential for morbidity and mortality through association with increased risk for HIV infection. Case-control survey was conducted using Rapid Plasma Reagin test and confirmatory Immunochromatographic test among HIV-positive (cases) and HIV-negative (control) Nigerians. A total of 35(14.0%) of 250 HIV-positive and 5(2.0%) of 250 HIV-negative individuals studied were seropositive for syphilis, the difference was statistically significant (P<0.05). The prevalence was higher among females than males of HIV-positive (15.0% versus 12.7%) and of the HIV-negative (2.1% versus 1.9%) individuals. Syphilis seroprevalence was highest among HIV-positive individuals aged 21-30 years (20.5%) and 41-50 years old HIV-negative individuals (4.5%). Sex education, promotion of safer sexual behaviour, prompt diagnosis of STDs and provision of effective, accessible treatment are recommended

Item Type:Journal (On-line/Unpaginated)
Keywords:Syphilis, Treponema pallidum, HIV, Seroprevalence
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:5169
Deposited By:Kakkilaya Bevinje, Dr. Srinivas
Deposited On:25 Sep 2006
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva:World Health Organization; 2001.

2. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351:5-7.

3. Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004;22:461-468.

4. Tramont EC. Syphilis in adults: From Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis. 1995;21:1361-1369.

5. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987;316:1569-1572.

6. O'Mahony C, Rodgers CA, Mendelsohn SS, et al. Rapidly progressive syphilis in early HIV infection. Int J Sex Trans Dis AIDS. 1997;8:275-277.

7. Bolan G. Syphilis and HIV. HIV InSite Knowledge Base Chapter. 1998. Available at: http://hivinsite.ucsf.edu/InSite?page=kb-05&doc=kb-05-01-04. Accessed February 5, 2006.

8. Wasserheit JN. Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.

9. Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull WHO. 2004;82:402-409.

10. World Health Organization (WHO). AIDS epidemic update. Geneva: UNAIDS/WHO; 2004.

11. Ministry of Health South Africa (MOHSA). National HIV and Syphilis Sero-Prevalence Survey of Women attending Public Antenatal Clinics in South Africa. Johannesburg: MOHSA; 2001.

12. Federal Ministry of Health Nigeria (FMOHN). Technical report on 2001 national HIV/syphilis sentinel survey among pregnant women attending antenatal clinics in Nigeria. Abuja: FMOHN; 2004.

13. Tsegaye A, Rinke de Wit TF, Mekonnen Y, et al. Decline in the prevalence of HIV- infection and syphilis among women attending antenatal care clinic in Addis Ababa, Ethiopia: Results from sentinel surveillance, 1995-2001. J Acquir Immune Syndr. 2002;30:359-362

14. United Nations System in Nigeria (UNSN). Nigerian Common Country Assessment.Geneva: World Health Organization; 2001.

15. Cheesbrough M. District Laboratory Practice in Tropical Countries. Part 2. Cambridge University Press; 2000.

16. U.S. Preventive Services Task Force (USPSTF). Screening for Syphilis: Brief Update. Agency for Healthcare Research and Quality, Rockville, MD. 2004. Available at: http://www.ahrq.gov/clinic/3rduspstf/syphilis/syphilup.htm. Accessed February 5, 2006.

17. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986;104:368-376.

18. Dorigo-Zetsma JW, Belewu D, Meless H, et al. Performance of routine syphilis serology in the Ethiopian cohort on HIV/AIDS. Sex Transm Infect. 2004;80:96-99.

19. Golden MR, Marra CM, Holmes KK. Update on syphilis: Resurgence of an old problem. JAMA. 2003;290:1510-1514.

20. Rodriguez I, Rodriguez ME, Fernandez C, et al. Serological diagnosis of syphilis in Cuban HIV/AIDS patients. Rev Cubana Med Trop. 2004;56:67-69.

21. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:704-709.

22. Uneke CJ, Ogbu O, Inyama PU, et al. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria Mem Inst Oswaldo Cruz. 2005;100:13-16.

23. Nusbaum MR, Wallace RR, Slatt LM, et al. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopathol Assoc. 2004;104: 527-35.

24. Rompalo AM, Cannon RO, Quinn TC, et al. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis. 1992;165:1124-1126.

25. Young H. Syphilis: new diagnostic directions [editorial review]. International J Sex Transm Dis AIDS. 1992;3:391-413.

26. Augenbraun MH, DeHovitz JA, Feldman J. Biologic false-positive syphilis test results for women infected with human immunodeficiency virus. Clin Infect Dis. 1994;19:1040– 1044.

27. Erbelding EJ, Vlahov D, Nelson KE, et al. Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis.1997;176:1397–1400.

28. Centers for Disease Control and Prevention (CDC). National Center for HIV, and TB Prevention, Prevention DoS. Sexually transmitted disease surveillance 2001 supplement: Syphilis surveillance report. Atlanta, GA: Department of Health and Human Services; 2003.

29. Hwang LY, Ross MW, Zack C, et al. Prevalence of STIs and association risk factors among population of drug abuse. J Clin Infect. 2000;319:920-926.

30. Todd J, Muguti K, Grosskurlt H, et al. Risk factors for active syphilis and TPHA seroconversion in a rural Africa population. J Sex Transm Infect. 2001;7:37-45.

31. Gourevitch MN, Hartel D, Schenbaum EE, et al. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx. Am J Pub Health. 1996;86:1112- 1115.

32. World Health Organization (WHO). The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.

33. International Development Research Centre (IDRC). Population and Health in Developing Countries, Vol 1. Ottawa: Population health and survival at INDEPTH sites; 2002.

Metadata

Repository Staff Only: item control page